ARENCIA Retinal Booster Shot 30ml
Original price was: 1,300.00EGP.1,000.00EGPCurrent price is: 1,000.00EGP.-23% OFF
If you’re in need an anti-aging boost that packs a punch, check out Arencia’s Retinal Booster Shot for next-level youth-restoring care. The booster treatment is a whiz at minimizing fine lines and revitalizing tired skin with a formula containing Retin-A Complex, caffeine and peptides.
In stock
- High-potency retinal boosting treatment that promotes plump and youthful complexion.
- Formulated with exclusive Retin-A Complex ingredients to boost skin elasticity and reduce the appearance of fine lines and wrinkles.
- Enriched with soothing ingredients like Centella Asiatica Extract, Ectoin, and Ceramide to minimize the possible irritation from retianl.
- Contains Caffeine and Peptide to vitalize and nourish skin.
- Lightweight gel cream texture that does not feel stuffy or heavy on skin.
Apply an appropriate amount on clean skin before the mositurizer step of skincare routine. Gently tap to aid absorption.
Water, Glycerin, Methylpropanediol, Butylene Glycol, Caprylic/Capric Triglyceride, 1,2-Hexanediol, Niacinamide, Cetyl Ethylhexanoate, Cetearyl Olivate, Polyglyceryl-3 Methylglucose Distearate, Diisostearyl Malate, Sodium Polyacrylate, Sorbitan Olivate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Arginine, Macadamia Ternifolia Seed Oil, Hydrogenated Lecithin, Ethylhexylglycerin, Adenosine, Gardenia Florida Fruit Extract, Xanthan Gum, Cholesterol, Polyglyceryl-10 Laurate, Allantoin, Retinal(200ppm), Silica, Brassica Campestris (Rapeseed) Sterols, Dextrin, Panthenol, Tocopherol, Aluminum/Magnesium Hydroxide Stearate, Potassium Cetyl Phosphate, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Caffeine, Disodium EDTA, Ectoin, Bakuchiol, Ceramide NP, Centella Asiatica Extract, Glycosphingolipids, Palmitoyl Pentapeptide-4, Hexapeptide-2, Hexapeptide-9, Tripeptide-1, Pentapeptide-3, Palmitoyl Tripeptide-1, Palmitoyl Tripeptide-5, Acetyl Hexapeptide-8, Copper Tripeptide-1





Reviews
There are no reviews yet.